Loading…

SFINX - Owned by TransForm Pharmaceuticals, Inc. - (Class 042) | Sealvo

Home Search: SFINXSFINX #76467513

Updated Sep 19, 2026·40 searches this week

View on USPTO TSDR Find similar marks

SFI

USPTO Trademark Record

ABANDONED

SFINX

SN 76467513·Reg 2814647·Filed Nov 18, 2002

Owner TransForm Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

SFINX (Serial No. 76467513), Registration No. 2814647, is a abandoned US trademark filed on Nov 18, 2002 by TransForm Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Conflict Analysis

Full conflict analysis for SFINX (SN 76467513) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

SFINX (Reg. #2814647) is an abandoned US trademark that was filed in 2002 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 18, 2002

SERIAL

76467513

REG#

2814647

REGISTERED

Feb 17, 2004

Filing Information

StatusABANDONED

Filing DateNov 18, 2002

Serial Number76467513

Registration No.2814647

Registration DateFeb 17, 2004

Status DateSep 24, 2010

Published for OppositionNov 25, 2003

Filing Basis & Declarations

Filed as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

1

OFFICE

USPTO

COUNTRY

US

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 01, 2002

First use in commerce: Jun 01, 2002

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

14 events

CANCELLED SEC. 8 (6-YR)

Sep 24, 2010

CANCELLED SEC. 8 (6-YR)

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 05, 2004

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 23, 2004

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Feb 17, 2004

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 25, 2003

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Nov 05, 2003

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 24, 2003

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 11, 2003

CORRESPONDENCE RECEIVED IN LAW OFFICE

FAX RECEIVED

Sep 11, 2003

FAX RECEIVED

CASE FILE IN TICRS

Aug 18, 2003

CASE FILE IN TICRS

PAPER RECEIVED

Jul 25, 2003

PAPER RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 25, 2003

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION E-MAILED

Mar 31, 2003

NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 27, 2003

ASSIGNED TO EXAMINER

Other Marks by TransForm Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

SHAPING THE MEDICINES OF TOMORROW

76477998

TransForm Pharmaceuticals, Inc.

SHAPING THE MEDICINES OF TOMORROW

77441406

TRANSFORM PHARMACEUTICALS, INC.

TRANSFORM

75859999

TransForm Pharmaceuticals, Inc.

TRANSFORM

75859687

TransForm Pharmaceuticals, Inc.

Other Marks by John M. Lucas

Additional USPTO filings handled by the same attorney of record.

DERMAX

78308807

LogoMark

76506201

LogoMark

76467512